國立虎尾科技大學 |

Treating urothelial bladder cancer

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Treating urothelial bladder cancer/ edited by Francesco Soria, Paolo Gontero.
other author:	Soria, Francesco.
Published:	Cham :Springer International Publishing : : 2018.,
Description:	viii, 133 p. :digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Bladder - Cancer -
Online resource:	http://dx.doi.org/10.1007/978-3-319-78559-2
ISBN:	9783319785592

Treating urothelial bladder cancer
Treating urothelial bladder cancer[electronic resource] /edited by Francesco Soria, Paolo Gontero. - Cham :Springer International Publishing :2018. - viii, 133 p. :digital ;24 cm.

Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist.

This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer. Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management.

ISBN: 9783319785592

Standard No.: 10.1007/978-3-319-78559-2doiSubjects--Topical Terms:

783754
Bladder
--Cancer

LC Class. No.: RC280.B5 / T743 2018

Dewey Class. No.: 616.9946206

Treating urothelial bladder cancer
LDR:02911nam a2200313 a 4500 001 928042
003 DE-He213
005 20190130152358.0
006 m d
007 cr nn 008maaau
008 190626s2018 gw s 0 eng d
020 $a 9783319785592 $q (electronic bk.)
020 $a 9783319785585 $q (paper)
024 7 $a 10.1007/978-3-319-78559-2 $2 doi
035 $a 978-3-319-78559-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B5 $b T743 2018
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
082 0 4 $a 616.9946206 $2 23
090 $a RC280.B5 $b T784 2018
245 0 0 $a Treating urothelial bladder cancer $h [electronic resource] / $c edited by Francesco Soria, Paolo Gontero.
260 $a Cham : $c 2018. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 133 p. : $b digital ; $c 24 cm.
505 0 $a Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist.
520 $a This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer. Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management.
650 0 $a Bladder $x Cancer $x Treatment. $3 783754
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Urology. $3 645258
650 2 4 $a Oncology. $3 593951
650 2 4 $a Radiotherapy. $3 593952
700 1 $a Soria, Francesco. $3 1207768
700 1 $a Gontero, Paolo. $3 1075483
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-78559-2
950 $a Medicine (Springer-11650)